[Research Report] The microfluidics market size is estimated to reach US$ 43,398.7 million by 2027 from US$ 11,851.1 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2019 to 2027.
Market Insights and Analyst View:
Microfluidics is both science and technology, as the science it studies the behavior of fluids through micro-channels, and as the technology of manufacturing microminiaturized devices containing chambers and tunnels through which fluids flow. Microfluidics deal with small volumes of fluids, down to femtoliters (fL), a quadrillionth liter. As more and more researchers realize the power of microfluidics, the technology is being applied to many new fields, thus saving money and time spent on research. Microfluidic systems are widely used in procedures such as isoelectric focusing, capillary electrophoresis, flow cytometry, immunoassays, sample injection in mass spectrometry, DNA analysis, PCR amplification, cell patterning, and separation and manipulation of cells. The rising demand for microfluidics technologies in point-of-care testing and innovation in the microfluidics product portfolio is expected to propel the microfluidics market growth during the forecast period.
Growth Drivers:
The advances in the design and development of microfluidics (MFs) devices have made it possible to miniaturize conventional biochemical laboratory protocols into a microchannel networking system, which has emerged as an efficient and cost-effective tool. Biomedical microdevices include integrated structures consisting of numerous micro- and nano-sized integrated devices, where many processes, from particle manipulation to sensing, take place in the platform. Although different types of microfluidic devices can perform similar tasks in biomedical applications, passive microfluidic systems are mainly used for particle manipulation and mixing liquids. In contrast, active types contribute more to particle trapping and sensing. One of the most promising applications of microfluidics in biomedical sciences is the diagnosis of diseases, including cancer diagnosis and infectious diseases. However, further development of microfabrication permits employing microfluidics devices in tissue engineering and organ-on-a-chip. Moreover, microfluidics–biosensing technology has become popular for applications such as point-of-care testing, biosensors, and cell manipulations.
Cancer is one of the leading causes of death globally. Microfluidics holds great promise in cancer diagnosis and is an emerging tool for understanding cancer biology. For instance, according to GLOBOCAN, in 2020, there were 19,282,789 new cancer cases worldwide, which is anticipated to rise to 28,887,940 cases by 2040. Microfluidics can be valuable for cancer investigation due to its high sensitivity, high throughput, less material consumption, low cost, and enhanced spatiotemporal control. The physical laws on the microscale offer an advantage enabling the control of physics, biology, chemistry, and physiology at a cellular level. Thus, an expected increase in cancer cases is anticipated to increase the demand for point-of-care diagnostics, propelling the market's growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Microfluidics Market: Strategic Insights
Market Size Value in US$ 11,851.1 million in 2019 Market Size Value by US$ 43,398.7 million by 2027 Growth rate CAGR of 17.9% from 2019 to 2027. Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Microfluidics Market: Strategic Insights
| Market Size Value in | US$ 11,851.1 million in 2019 |
| Market Size Value by | US$ 43,398.7 million by 2027 |
| Growth rate | CAGR of 17.9% from 2019 to 2027. |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Microfluidics Market” is segmented based on product, application, sector, and geography. Based on the product, the microfluidics market is segmented into microfluidic chips, microfluidic sensors, micropumps, microneedles, devices, and other products. Based on material, the microfluidics market is segmented into PDMS, polymers, glass, silicon, and others. Based on application, the microfluidics market is divided into vitro diagnostics, pharmaceutical and life science research, drug discovery, and other applications. The microfluidics market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The microfluidics market by product is segmented into microfluidic chips, microfluidic sensors, micropumps, microneedles, devices, and other products. The devices segment held the largest share of the market in 2019. However, microfluidic chips are anticipated to register the highest CAGR in the market during the forecast period. Microfluidic devices have great potential to synthesize nanoparticles and nanocomposites due to the efficient heat and mass transfers and spatial limitations in microfluidic devices, convenient parameter adjustments, and in situ process monitoring in microreactors. Many nanoparticles with controllable sizes, size distributions, and morphologies, such as organic, inorganic, and hybrid, have been successfully synthesized in microfluidic devices. Also, the microfluidic devices used for biomedical applications include single-cell trapping, automated micro-robotic injection, and drug discovery and analysis. Thus, the factors mentioned above are likely to anticipate the growth of devices in the market.
Microfluidics Market, by Product – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on application, the microfluidics market is divided into in vitro diagnostics, pharmaceutical, and life science research, drug discovery, and other applications. The In-vitro diagnostics segment held the largest share of the market in 2019. and the same segment is anticipated to register the highest CAGR in the market during the forecast period. Microfluidics, or lab-on-a-chip technology, is a tool that sits at the intersection of automation, biotechnology, and functional integration. By using photolithography and other CMOS fabrication techniques to make fluid flow cells, microfluidic devices can shuttle the picoliter, and smaller volumes of fluids into functional regions, enabling powerful in vitro diagnostics (IVD) harnessing everything from digital biology, to next-generation sequencing, to organs-on-a-chip, to high throughput cell-based assays, to high-density multifunctional chips for drug discovery and bioanalysis, for the shrinking sample and reagent volumes. The microfluidics materials used in in vitro diagnostics are primarily glass, silicon, and polymers (plastics and photoresists).
Regional Analysis:
Based on geography, the microfluidics market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The north bioinformatics market has been analyzed based on three major countries — the US, Canada, and Mexico. The US is estimated to hold the largest microfluidics market share during the forecast period. The growth of the market in the country is primarily driven by technological advancements, the launch of new and advanced products, and increasing R&D activities in the country.
Asia Pacific is the fastest-growing market for microfluidics. The market growth in this region is attributed to several growth opportunities, such as product launches, a rise in R&D investments, and increasing government initiatives. Additionally, the presence of major players fuels the market's growth.
Microfluidics Market Trend:
Microfluidic chips are microchannels engraved on glass, silicone, and polymer materials. The small size makes them attractive for laboratory and point‐of‐care (POC) settings. 3D printing is increasingly being adopted to fabricate microfluidic chips as the technology greatly reduces the transition time. In the last few years, 3D printing has emerged as a promising alternative for fabricating microfluidic devices, overcoming some of the limitations of conventional soft-lithography. Due to their availability and affordability, Stereolithography (SLA), inkjet 3D printing, and extrusion-based technology are three of the broadly used 3D printing technologies. Microfluidic devices can be 3D printed using four fundamental manufacturing approaches: direct printing, mold-based, modular, and hybrid. Using a broad spectrum of additive manufacturing materials, 3D-printed microfluidic devices have been implemented in various fields, including biological, chemical, and material synthesis.
A few examples of 3D printing in Microfluidics are mentioned below:
In June 2020, researchers at the University of California pioneered a new droplet-based 3D printing technology using microfluidics. This approach will help the researchers print finely-tuned flexible materials with applications in tissue engineering, soft robotics, and wearable technology.
In June 2020, scientists at the Montana State University’s Department of Mechanical and Industrial Engineering developed a new method for 3D printing microfluidic devices. This method is capable of 3D printing directly onto a glass substrate to create thin fluid channels measuring less than a millimeter in width. The novel process is faster and cheaper than other conventional microfluidic production methods.
Covid-19 Impact:
Coronavirus diagnostic with microfluidics has gained a lot of attention. For instance, US-based researchers from Broad Institute have developed a CRISPR-based molecular diagnostics stage with the help of microfluidics chips to detect viruses in human samples. This single chip has the potential to detect a single virus in more than 1,000 samples at a time. Additionally, it can search a smaller number of samples for more than 160 different viruses, including SARS-CoV-2, the virus accountable for the COVID-19 pandemic. Moreover, many organizations are contributing their efforts to the detection of COVID-19; for instance, SkyWater Technology and SEMI-Fab Owners Alliance are on the front lines in providing a necessary microfluidic MEMS component used in COVID-19 testing and research to identify mutations of the virus. US-based SkyWater has been working with genomics sequencing leader MGI to supply a component used in an ultra-high-throughput sequencing system, namely, MGI's DNBSEQ-T7. The component provided is a microfluidic MEMS device that uses microscopic channels to perform small-scale chemical reactions in the genetic sequencing platform.
Moreover, nanomaterials have been used in several real-time sensing platforms. However, academic researchers and the nanotechnology industry are creating point-of-care devices that use nanomaterial as the sensing element. These devices were created as either microfluidic-based devices or nanosensor devices. Such microfluidic-based devices have helped fight against COVID-19, prevented severe shortages of healthcare resources, provided a real-time diagnosis of this disease, and minimized death rates.
Competitive Landscape and Key Companies:
Agilent Technologies, Inc., BD, Bio-Rad Laboratories Inc., Danaher, Dolomite Microfluidics (Blacktrace Holdings Ltd.), Fludigm Corporation, Illumina, Inc. microfluidic ChipShop GmbH, Perkin Elmer, Inc., and Thermo Fisher Scientific Inc. are the microfluidics companies operating in the market. Microfluidics companies focus on new technologies, existing product advancements, and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. For instance, in March 2022, Miroculus, Inc. announced the formal launch of the Miro Canvas. This compact, easy-to-use digital microfluidics platform enables on-demand automation of complex next-generation sequencing (NGS) sample preparation protocols.
- In October 2021, LumiraDx submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the Food and Drug Administration (FDA) for Emergency Use Authorization (EUA). The microfluidic immunofluorescence assay can quickly verify infection for patients suspected of flu and COVID-19 to aid in diagnosis and clinical decision-making.
- In January 2021, LexaGene launched the MiQLab system from research-only use to POC use to detect the SARS-CoV-2 virus after receiving emergency use authorization (EUA) in the United States.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Material, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global microfluidics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The North American region held the largest market share in the global scenario. Factors such as technological advancements, new product launches and increasing R&D activities are likely to be responsible for the domination of North America in the microfluidics market. In addition, growing research technologies, and novel methods for manufacturing liposomes are also expected to boost the growth of the market in North America.
Microfluidics involves processing or manipulation of small amount of fluidics. It studies various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. Microfluidics is an emerging technology having a wide range of applications in biology, chemistry, optics and information technology. This technology is widely used for various processes such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, PCR amplification, among others. Additionally, microfluidics is also used in the diagnosis of diseases such as cancer and research.
Factors such as rising demand for microfluidics technologies in point-of-care testing and innovation in microfluidics product portfolio are expected to boost the growth of the global microfluidics market. However, the market is likely to get impacted by the lower adoption in emerging economies during the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Microfluidics Market – By Product
1.3.2 Microfluidics Market – By Material
1.3.3 Microfluidics Market – By Application
1.3.4 Microfluidics Market – By Geography
2. Microfluidics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Microfluidics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South & Central America
4.3 Expert Opinion
5. Global Microfluidics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Microfluidics Technologies in Point-Of-Care Testing
5.1.2 Innovation in Microfluidics Product Portfolio
5.2 Market Restraints
5.2.1 Lower Adoption in Emerging Economies
5.3 Market Opportunities
5.3.1 Increasing Potential of Microfluidics in Drug Discovery
5.4 Future Trends
5.4.1 3D Printing in Microfluidics
5.5 Impact Analysis
6. Microfluidics Market – Global Analysis
6.1 Global Microfluidics Market Revenue Forecast And Analysis
6.2 Global Microfluidics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Microfluidics Market– By Product
7.1 Overview
7.2 Microfluidics Market Revenue Share, by Product (2019 and 2027)
7.3 Microfluidic Chips
7.3.1 Overview
7.3.2 Microfluidic Chips: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Microfluidic Sensors
7.4.1 Overview
7.4.2 Microfluidic Sensors: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Micropumps
7.5.1 Overview
7.5.2 Micropumps: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Microneedles
7.6.1 Overview
7.6.2 Microneedles: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Devices
7.7.1 Overview
7.7.2 Devices: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Other Products
7.8.1 Overview
7.8.2 Other Products: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
8. Microfluidics Market Analysis, by Material
8.1 Overview
8.2 Microfluidics Market Revenue Share, by Material (2019 and 2027)
8.3 Polymers
8.3.1 Overview
8.3.2 Polymers: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Glass
8.4.1 Overview
8.4.2 Glass: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Silicon
8.5.1 Overview
8.5.2 Silicon: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
8.6 PDMS (Polydimethylsiloxane)
8.6.1 Overview
8.6.2 PDMS (Polydimethylsiloxane): Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Other Materials
8.7.1 Overview
8.7.2 Other Materials: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
9. Microfluidics Market Analysis, by Application
9.1 Overview
9.2 Microfluidics Market Revenue Share, by Application (2019 and 2027)
9.3 In Vitro Diagnostics
9.3.1 Overview
9.3.2 In Vitro Diagnostics: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
9.3.3 Point-of-Care Testing
9.3.3.1 Overview
9.3.3.2 Point of Care Testing (POCT) Market: Microfluidics Market– Revenue and Forecast to 2027 (US$ Million)
9.3.4 Clinical Diagnostics
9.3.4.1 Overview
9.3.4.2 Clinical Diagnostics: Microfluidics Market– Revenue and Forecast to 2027 (US$ Million)
9.4 Pharmaceutical and Life Science Research
9.4.1 Overview
9.4.2 Pharmaceutical and Life Science Research: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Drug Discovery
9.5.1 Overview
9.5.2 Drug Discovery: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Other Applications
9.6.1 Overview
9.6.2 Other Applications: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
10. Microfluidics Market – Geographic Analysis
10.1 North America: Microfluidics Market
10.1.1 Overview
10.1.2 North America: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.1.5 North America: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.1.5.1 North America: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.1.6 North America: Microfluidics Market, by Country, 2019& 2027 (%)
10.1.7 US: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.1.7.3 US: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.1.7.4 US: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.1.7.4.1 US: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.1.8 Canada: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.1.8.4 Canada: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.1.8.4.1 Canada: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.1.9 Mexico: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.1.9.4 Mexico: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.1.9.4.1 Mexico: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.2 Europe: Microfluidics Market
10.2.1 Overview
10.2.2 Europe: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.2.4 Europe: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.2.5 Europe: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.2.5.1 Europe: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.2.6 Europe: Microfluidics Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.2.7.3 Germany: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.2.7.4 Germany: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.2.7.4.1 Germany: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.2.8 UK: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.2.8.3 UK: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.2.8.4 UK: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.2.8.4.1 UK: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.2.9 France: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.2.9.3 France: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.2.9.4 France: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.2.9.4.1 France: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.2.10 Spain: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.2.10.3 Spain: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.2.10.4 Spain: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.2.10.4.1 Spain: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.2.11 Italy: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.2.11.3 Italy: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.2.11.4 Italy: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.2.11.4.1 Italy: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.3 Asia Pacific: Microfluidics Market
10.3.1 Overview
10.3.2 Asia Pacific: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.3.5.1 Asia Pacific: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.3.6 Asia Pacific: Microfluidics Market, by Country, 2019 & 2027 (%)
10.3.7 China: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.3.7.3 China: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.3.7.4 China: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.3.7.4.1 China: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.3.8 Japan: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.3.8.3 Japan: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.3.8.4 Japan: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.3.8.4.1 Japan: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.3.9 India: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.3.9.3 India: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.3.9.4 India: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.3.9.4.1 India: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.3.10 South Korea: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.3.10.3 South Korea: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.3.10.4 South Korea: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.3.10.4.1 South Korea: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.3.11 Australia: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.3.11.3 Australia: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.3.11.4 Australia: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.3.11.4.1 Australia: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.4 Middle East & Africa: Microfluidics Market
10.4.1 Overview
10.4.2 Middle East & Africa: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.4.4 Middle East & Africa: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.4.5 Middle East & Africa: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.4.5.1 Middle East & Africa: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.4.6 Middle East & Africa: Microfluidics Market, by Country, 2018 & 2027 (%)
10.4.7 Saudi Arabia: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.4.7.4.1 Saudi Arabia: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.4.8 UAE: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.4.8.3 UAE: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.4.8.4 UAE: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.4.8.4.1 UAE: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.4.9 South Africa: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.4.9.3 South Africa: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.4.9.4 South Africa: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.4.9.4.1 South Africa: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.5 South and Central America: Microfluidics Market
10.5.1 Overview
10.5.2 South and Central America: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.5.4 South and Central America: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.5.5 South and Central America: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.5.5.1 South and Central America: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.5.6 South and Central America: Microfluidics Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.5.7.3 Brazil: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.5.7.4 Brazil: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.5.7.4.1 Brazil: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
10.5.8 Argentina: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Microfluidics Market, by Product, 2018–2027 (USD Million)
10.5.8.3 Argentina: Microfluidics Market, by Material, 2018–2027 (USD Million)
10.5.8.4 Argentina: Microfluidics Market, by Application, 2018–2027 (USD Million)
10.5.8.4.1 Argentina: Microfluidics Market, by In Vitro Diagnostics, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Microfluidics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Microfluidics Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic and Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Danaher
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Perkin Elmer, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Dolomite Microfluidics (Blacktrace Holdings Ltd.)
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BIO-RAD LABORATORIES INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 microfluidic ChipShop GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Fludigm Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Illumina, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BD
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
LIST OF TABLES
Table 1. North America Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 5. US Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. US Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 7. US Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 8. US Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 25. UK Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 26. UK Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 27. UK Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 28. UK Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 29. France Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 30. France Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 31. France Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. France Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 41. Asia Pacific Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 42. Asia Pacific Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 43. Asia Pacific Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 44. Asia Pacific Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 45. China Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 46. China Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 47. China Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 48. China Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 49. Japan Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 50. Japan Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 51. Japan Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 52. Japan Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 53. India Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 54. India Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 55. India Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 56. India Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 57. South Korea Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 58. South Korea Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 59. South Korea Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 60. South Korea Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 61. Australia Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 62. Australia Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 63. Australia Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 64. Australia Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 65. Middle East & Africa Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 66. Middle East & Africa Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 67. Middle East & Africa Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 68. Middle East & Africa Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 69. Saudi Arabia Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 70. Saudi Arabia Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 71. Saudi Arabia Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 72. Saudi Arabia Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 73. UAE Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 74. UAE Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 75. UAE Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 76. UAE Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 77. South Africa Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 78. South Africa Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 79. South Africa Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 80. South Africa Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 81. South and Central America Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 82. South and Central America Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 83. South and Central America Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 84. South and Central America Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 85. Brazil Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 86. Brazil Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 87. Brazil Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 88. Brazil Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 89. Argentina Microfluidics Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 90. Argentina Microfluidics Market, by Material – Revenue and Forecast to 2027 (USD Million)
Table 91. Argentina Microfluidics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 92. Argentina Microfluidics Market, by In Vitro Diagnostics– Revenue and Forecast to 2027 (USD Million)
Table 93. Developments Done By Companies
Table 94. Glossary of Terms, Microfluidics Market
LIST OF FIGURES
Figure 1. Microfluidics Market Segmentation
Figure 2. Microfluidics Market – By Geography
Figure 3. Global Microfluidics Market Overview
Figure 4. Devices Segment Held Largest Share of Microfluidics Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Global Microfluidics Market, By Geography (US$ Million)
Figure 7. Global Microfluidics Market- Leading Country Markets (US$ Million)
Figure 8. Global Microfluidics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Microfluidics Market Impact Analysis of Driver and Restraints
Figure 16. Global Microfluidics Market – Revenue Forecast And Analysis – 2019- 2027
Figure 17. Global Microfluidics Market – By Geography Forecast and Analysis – 2019- 2027
Figure 18. Market Positioning of Key Players
Figure 19. Microfluidics Market Revenue Share, by Product (2019 and 2027)
Figure 20. Microfluidic Chips: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Microfluidic Sensors: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Micropumps: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Microneedles: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Devices: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Other Products: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Microfluidics Market Revenue Share, by Material (2019 and 2027)
Figure 27. Polymers: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Glass: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Silicon: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. PDMS (Polydimethylsiloxane): Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Other Materials : Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Microfluidics Market Revenue Share, by Application (2019 and 2027)
Figure 33. In Vitro Diagnostics: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Point of Care Testing (POCT) Market: Microfluidics Market– Revenue and Forecast to 2027 (US$ Million)
Figure 35. Clinical Diagnostics: Market: Microfluidics Market– Revenue and Forecast to 2027 (US$ Million)
Figure 36. Pharmaceutical and Life Science Research : Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 37. Drug Discovery : Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 38. Other Applications: Microfluidics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 39. North America: Microfluidics Market, by Key Country – Revenue (2019) (USD Million)
Figure 40. North America Microfluidics Market Revenue and Forecast to 2027 (USD Million)
Figure 41. North America: Microfluidics Market, by Country, 2019 & 2027 (%)
Figure 42. US: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Canada: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Mexico: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Europe: Microfluidics Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. Europe Microfluidics Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Europe: Microfluidics Market, by Country, 2019 & 2027 (%)
Figure 48. Germany: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. UK: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. France: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Spain: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Italy: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Asia Pacific: Microfluidics Market, by Key Country – Revenue (2019) (USD Million)
Figure 54. Asia Pacific Microfluidics Market Revenue and Forecast to 2027 (USD Million)
Figure 55. Asia Pacific: Microfluidics Market, by Country, 2019 & 2027 (%)
Figure 56. China: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Japan: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. India: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. South Korea: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Australia: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. Middle East & Africa: Microfluidics Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. Middle East & Africa Microfluidics Market Revenue and Forecast to 2027 (USD Million)
Figure 63. Middle East & Africa: Microfluidics Market, by Country, 2018 & 2027 (%)
Figure 64. Saudi Arabia: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. UAE: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. South Africa: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. South and Central America: Microfluidics Market, by Key Country – Revenue (2019) (USD Million)
Figure 68. South and Central America Microfluidics Market Revenue and Forecast to 2027 (USD Million)
Figure 69. South and Central America: Microfluidics Market, by Country, 2019 & 2027 (%)
Figure 70. Brazil: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 71. Argentina: Microfluidics Market – Revenue and Forecast to 2027 (USD Million)
Figure 72. Impact of COVID-19 Pandemic on Microfluidics Market in North American Countries
Figure 73. Impact of COVID-19 Pandemic on Microfluidics Market in European Countries
Figure 74. Impact of COVID-19 Pandemic on Microfluidics Market in Asia Pacific Countries
Figure 75. Impact of COVID-19 Pandemic on Microfluidics Market in Rest of the World
Figure 76. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Microfluidics Market
- Agilent Technologies, Inc.
- BD
- Bio-Rad Laboratories Inc.,
- Danaher
- Dolomite Microfluidics (Blacktrace Holdings Ltd.)
- Fludigm Corporation
- Illumina, Inc.
- microfluidic ChipShop GmbH
- Perkin Elmer, Inc.
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Microfluidics Market
Jul 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jul 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jul 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jul 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jul 2020